Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
Elke Jordan, Steven J. Lawrence, Thomas P.H. Meyer, Darja Schmidt, Stephanie Schultz, Jutta Mueller, Daria Stroukova, Brigitte Koenen, Robert Gruenert, Guenter Silbernagl, Sanja Vidojkovic, Liddy M. Chen, Heinz Weidenthaler, Nathaly Samy, Paul Chaplin
Dive into the research topics of 'Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine'. Together they form a unique fingerprint.